Mythic Study

Phase I study of RP-6306: oral agent for solid tumors with mutations in CCNE1, FBXW7 or PPP2R1A. (Mythic Study)
Status:

Open

Trial Type:
Early Phase Trials for Multiple Cancer Types

Contact:

Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org

©2023 Brown Cancer Clinical Trials